- Home
- Funding Opportunities
- Advisory Boards
- President's Cancer Panel
- National Cancer Advisory Board
- Board of Scientific Advisors
- Board of Scientific Counselors
- Clinical Trials and Translational Research Advisory Committee
- NCI Council of Research Advocates
- Frederick National Laboratory Advisory Committee
- NCI Initial Review Groups
- Special Emphasis Panel
- Office of Federal Advisory Committee Policy
- Board Presentations
- Grant Policies
- Consumer Advocates
- NCI
Consumer Guide to Peer Review
The NCI Consumer Guide to Peer Review has been prepared to serve first as an introduction and orientation to the National Cancer Institute (NCI) and its Research Programs and second to define your role as a consumer in the Peer Review of applications that support extramural clinical/population-based research conducted by Cancer Centers, Cooperative Groups, Program Projects, and projects submitted in response to Requests for Applications (RFAs) and Program Announcements (PAs). - Cancer
Dictionary for Peer Review
Cancer Dictionary for Peer Review is deigned to provide concise definitions of technical terms frequently used in applications for NCI-sponsored investigator-initiated research. The terms include those commonly associated with the molecular biology of cancer, immunology, and clinical oncology. These definitions, in association with the review process, will increase your familiarity and understanding of the biology and clinical aspects of cancer. We hope this will facilitate and make your participation in the Peer Review process more meaningful. - Office of Advocacy Relations
- NCI Council of Research Advocates
- NCI
Consumer Guide to Peer Review
- Awarded Research
President's Cancer Panel Meetings
Meeting Information
2023 Reducing Cancer Care Inequities: Leveraging Technology to Enhance Patient Navigation | ||||
October 17 Hybrid - New Orleans, Louisiana Meeting Overview Agenda/Participants Minutes Meeting Link | November 2-3 Virtual Meeting Overview Agenda/Participants Minutes Meeting Link (November 2) Meeting Link (November 3) | December 7 Hybrid - Bethesda, Maryland Meeting Overview Agenda/Participants Minutes Meeting Link |
2023 President's Cancer Panel Initial Assessment of the National Cancer Plan | ||||
September 7 Virtual Meeting Overview Agenda/Participants Minutes |
2020-2022 Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access |
2021 Improving Resilience and Equity in Cancer Screening: Innovation to Increase Screening | ||||
February 11, 2021 Virtual Information Flyer Agenda/Participants Minutes |
2020 Improving Resilence and Equity in Cancer Screening: Lessons from COVID-19 and Beyond | ||||
October 26-28, 2020 Virtual Information Flyer Agenda/Participants Minutes | Novermber 2-4, 2020 Virtual Information Flyer Agenda/Participants Minutes | November 9-10, 2020 Virtual Information Flyer Agenda/Participants Minutes | November 16-18, 2020 Virtual Information Flyer Agenda/Participants Minutes |
2018-2019 Promoting Value, Affordability, and Innovation in Cancer Drug Treatment; HPV Vaccination for Cancer Prevention |
2016-2017 Ensuring Patients' Access to High-Value Cancer Drugs | |||
June 10, 2016 New York, NY Information Flyer Agenda/Participants Minutes Statement | December 9, 2016 Arlington, VA Information Flyer Agenda/Participants Minutes Statement | March 27, 2017 Philadelphia, PA Information Flyer Agenda/Participants Minutes Statement |
2014-2015 Connected Health: Improving Patients' Engagement and Activation for Cancer-Related Outcomes | ||||
December 11, 2014 Cambridge, MA Information Flyer Agenda/Participants Minutes Statement | March 26, 2015 San Francisco, CA Information Flyer Agenda/Participants Minutes Statement | July 9, 2015 Chicago, IL Information Flyer Agenda/Participants Minutes Presentations Statement |
Archive Meeting Information - 1973 to 2014 | Top |